Therapeutic challenge to adiposity of the heart

Circulation Research

Volumn 100, Issue 8, 2007, Pages 1106-1108

  Osanai, Tomohiro ^a   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Diabetes; Fatty acid transporter; Lipotoxic cardiomyopathy; Obesity

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL; GLUCOSE; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN; LIPID; LONG CHAIN FATTY ACID; MYOSIN HEAVY CHAIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

ANIMAL MODEL; CARDIOMYOPATHY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; EDITORIAL; FATTY ACID OXIDATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HEART; HEART DISEASE; HEART MUSCLE; HEART VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; INSULIN RESISTANCE; LIPID STORAGE; MALE; MOUSE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TRANSPORT; TRANSGENIC MOUSE; TREATMENT PLANNING;

ADIPOSITY; ANIMALS; ANTIGENS, CD36; CARDIOMYOPATHIES; FATTY ACIDS; GENE THERAPY; HUMANS; LIPOPROTEINS, LDL; OBESITY;

EID: 34247626363     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000266975.34924.b1     Document Type: Editorial

References (19)

1. Galloway JH, Cartwright IJ, Bennett MJ. Abnormal myocardial lipid composition in an infant with type II glutaric aciduria. J Lipid Res. 1987;28:279-284.
2. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest. 1989;83:927-936.
3. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Oric L, Unger RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000;97:1784-1789.
4. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest. 2001;107:813-822.
5. McGavock JM, Victor RG, Unger RH, Szczepaniak LS. Adiposity of the heart, revisited. Ann Intern Med. 2006;144:517-524.
6. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, Kelly DP. A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content. Proc Natl Acad Sci U S A. 2003;100:1226-1231.
7. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tnadon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood. 1992;80:1105-1115.
8. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, Nakata A, Ishigami M, Miyagawa J, Kameda-Takemura K, Kurata Y, Matsuzawa Y. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest. 1995;96:1859-1865.
9. Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem. 1993;268:17665-17668.
10. Greenwalt DE, Scheck SH, Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest. 1995;96:1382-1388.
11. Yagyu H, Chen G, Yokoyama M, Hirata K, Augustus A, Kako Y, Seo T, Hu Y, Lutz EP, Merkel M, Bensadoun A, Homma S, Goldberg IJ. Lipoprotein lipase (LpL) on the surface of acrdiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest. 2003;111:419-427.
12. Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res. 2005;96:225-233.
13. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP. The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002;109:121-130.
14. Yang J, Sambandam N, Han X, Gross RW, Courtois M, Kovacs A, Febbraio M, Finch BN, Kelly DP. CD36 deficiency rescues lipotoxic cardiomyopathy. Cir Res. 2007;100:1208-1217.
15. Hajri T, Han XX, Bonen A, Abumrad NA. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest. 2002;109:1381-1389.
16. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SFA, Silverstein RL. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem. 1999;274:19055-19062.
17. Tanaka T, Sohmiya K, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol. 1997;29:121-127.
18. Blanc J, Alves-Guerra MC, Esposito B, Rousset S, Gourdy P, Ricquier D, Tedgui A, Miroux B, Mallat Z. Protective role of uncoupling protein 2 in atherosclerosis. Circulation. 2003;107:388-390.
19. Bernal-Mizrachi C, Gates AC, Weng S, Imamura T, Knutsen RH, DeSantis P, Coleman T, Townsend RR, Muglia LJ, Semenkovich CF. Vascular respiratory uncoupling increases blood pressure and atherosclerosis. Nature. 2005;435:502-506.